UK Biobank cohort (n=259 146) | |
---|---|
Age (years) | 55.0±8.1 |
Male gender | 111 825 (43.2%) |
Smoking status | |
Non-smoker | 127 593 (49.2%) |
Former smoker | 99 255 (38.3%) |
Light smoker (<10 cigarettes/day) | 15 316 (5.9%) |
Moderate smoker (10–19 cigarettes/day) | 9320 (3.6%) |
Heavy smoker (≥20 cigarettes/day) | 7662 (3.0%) |
Social deprivation (Townsend score) | −1.4±3.0 |
Ethnic group | |
White or not recorded | 246 056 (94.9%) |
Indian | 2757 (1.1%) |
Pakistani | 788 (0.3%) |
Bangladeshi | 97 (0.0%) |
Other Asian | 862 (0.3%) |
Caribbean | 2162 (0.8%) |
Black African | 1575 (0.6%) |
Chinese | 804 (0.3%) |
Other | 4045 (1.6%) |
Clinical conditions | |
Family history of early heart disease | 28 102 (10.8%) |
Family history of diabetes | 23 161 (8.9%) |
Type 2 diabetes | 2131 (0.8%) |
Atrial fibrillation | 912 (0.4%) |
Rheumatoid arthritis | 2276 (0.9%) |
Chronic renal disease | 112 (0.0%) |
Treated with corticosteroids | 1953 (0.8%) |
Clinical values | |
Body mass index (kg/m2) | 26.8±3.9 |
Total cholesterol to high-density lipoprotein cholesterol ratio | 4.1±0.4 |
Systolic blood pressure (mm Hg) | 136.0±18.2 |
Data are presented as mean±SD for continuous variables and as frequencies (%) for categorical data.